We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 03, 2021

Long-Term Results of the TAX 323 Study in Unresectable Head and Neck Cancer Patients

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Prognostic Factor Analysis and Long-Term Results of the TAX 323 (EORTC 24971) Study in Unresectable Head and Neck Cancer Patients
Eur. J. Cancer 2021 Aug 20;156(xx)109-118, P Szturz, M Vinches, É Remenár, CML van Herpen, C Abdeddaim, JS Stewart, C Fortpied, JB Vermorken

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading